In contrast, in the PREVEND Study, a significant association was seen between copeptin and risk of diabetes, which was abolished after adjustment for components of the metabolic syndrome including WC, blood glucose, blood lipids, and hypertension in men. Here, AVP is linked to metabolic syndrome.